{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:51:48Z","timestamp":1781653908613,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Klinikum der Universit\u00e4t M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00405-026-10187-y","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:36:56Z","timestamp":1777426616000},"page":"3809-3817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tissue eosinophilia suggests dupilumab treatment response in chronic rhinosinusitis with nasal polyps (CRSwNP)"],"prefix":"10.1007","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6962-9999","authenticated-orcid":false,"given":"Patrick","family":"Huber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Braunschweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Frankenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Stihl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Gr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donata","family":"Gellrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Lasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"10","key":"10187_CR1","doi-asserted-by":"publisher","first-page":"e12200","DOI":"10.1002\/clt2.12200","volume":"12","author":"S Toppila-Salmi","year":"2022","unstructured":"Toppila-Salmi S et al (2022) The burden of chronic rhinosinusitis with nasal polyps and its relation to asthma in Finland. Clin Transl Allergy 12(10):e12200","journal-title":"Clin Transl Allergy"},{"issue":"3","key":"10187_CR2","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","volume":"9","author":"TM Laidlaw","year":"2021","unstructured":"Laidlaw TM et al (2021) Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract 9(3):1133\u20131141","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10187_CR3","doi-asserted-by":"publisher","first-page":"e12376","DOI":"10.1002\/clt2.12376","volume":"14","author":"T Mora","year":"2024","unstructured":"Mora T et al (2024) Prevalence and coexistence of type 2 inflammatory diseases. Clin Transl Allergy 14(6):e12376","journal-title":"Clin Transl Allergy"},{"issue":"Suppl S29","key":"10187_CR4","first-page":"1","volume":"58","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens WJ et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinol 58(Suppl S29):1\u2013464","journal-title":"Rhinology"},{"issue":"4","key":"10187_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","volume":"4","author":"WW Stevens","year":"2016","unstructured":"Stevens WW, Schleimer RP, Kern RC (2016) Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 4(4):565\u2013572","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"10187_CR6","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1111\/all.15301","volume":"77","author":"A Starry","year":"2022","unstructured":"Starry A et al (2022) Epidemiology and treatment of patients with Chronic rhinosinusitis with nasal polyps in Germany-A claims data study. Allergy 77(9):2725\u20132736","journal-title":"Allergy"},{"key":"10187_CR7","doi-asserted-by":"crossref","unstructured":"De Corso E et al (2022) Sinonasal biomarkers defining type 2-high and type 2-low inflammation in chronic rhinosinusitis with nasal polyps. J Pers Med, 12(8): 1251","DOI":"10.3390\/jpm12081251"},{"issue":"1","key":"10187_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaci.2020.11.013","volume":"147","author":"C Bachert","year":"2021","unstructured":"Bachert C et al (2021) EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol 147(1):29\u201336","journal-title":"J Allergy Clin Immunol"},{"key":"10187_CR9","doi-asserted-by":"publisher","first-page":"1285598","DOI":"10.3389\/fimmu.2024.1285598","volume":"15","author":"S AlBloushi","year":"2024","unstructured":"AlBloushi S, Al-Ahmad M (2024) Exploring the immunopathology of type 2 inflammatory airway diseases. Front Immunol 15:1285598","journal-title":"Front Immunol"},{"key":"10187_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/5584_2021_640","volume":"1347","author":"M Folci","year":"2021","unstructured":"Folci M et al (2021) Eosinophils as major player in type 2 inflammation: autoimmunity and beyond. Adv Exp Med Biol 1347:197\u2013219","journal-title":"Adv Exp Med Biol"},{"key":"10187_CR11","unstructured":"GmbH S-AD (2023) Dupixent 300\u00a0mg Injektionsl\u00f6sung im Fertigpen\/-in einer Fertigspritze. [cited 2023 17.08.2023]; Available from: https:\/\/www.rote-liste.de\/suche\/praep\/26905\/Dupixent%20300%20mg%20Injektionsl%C3%B6sung%20in%20einer%20Fertigspritze%20%20Fertigspritzen%20mit%20automatischem%20Sicherheitssystem"},{"issue":"8","key":"10187_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1055\/a-1197-0136","volume":"99","author":"L Klimek","year":"2020","unstructured":"Klimek L et al (2020) Positionspapier: anwendung von biologika bei chronischer rhinosinusitis mit polyposis nasi (CRSwNP) im Deutschen gesundheitssystem \u2013 empfehlungen des \u00e4rzteverbandes Deutscher allergologen (AeDA) und der AGs klinische immunologie, allergologie und umweltmedizin und rhinologie und rhinochirurgie der Deutschen gesellschaft f\u00fcr HNO-heilkunde, kopf- und halschirurgie (DGHNOKHC). Laryngorhinootologie 99(8):511\u2013527","journal-title":"Laryngorhinootologie"},{"issue":"1","key":"10187_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cea.13491","volume":"50","author":"H Harb","year":"2020","unstructured":"Harb H, Chatila TA (2020) Mechanisms Dupilumab. Clin Exp Allergy 50(1):5\u201314","journal-title":"Clin Exp Allergy"},{"key":"10187_CR14","doi-asserted-by":"crossref","unstructured":"Huber P et al (2024) Real-world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years. Allergy","DOI":"10.1111\/all.16263"},{"issue":"11","key":"10187_CR15","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1007\/s00405-024-08790-y","volume":"281","author":"H Frankenberger","year":"2024","unstructured":"Frankenberger H et al (2024) The use of biologics in patients suffering from chronic rhinosinusitis with nasal polyps - a 4-year real life observation. Eur Arch Otorhinolaryngol 281(11):5773\u20135782","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"10187_CR16","doi-asserted-by":"publisher","first-page":"100780","DOI":"10.1016\/j.waojou.2023.100780","volume":"16","author":"T Albrecht","year":"2023","unstructured":"Albrecht T et al (2023) Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy. World Allergy Organ J 16(5):100780","journal-title":"World Allergy Organ J"},{"issue":"10","key":"10187_CR17","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1111\/all.15772","volume":"78","author":"E De Corso","year":"2023","unstructured":"De Corso E et al (2023) Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational Phase IV real-life study (DUPIREAL). Allergy 78(10):2669\u20132683","journal-title":"Allergy"},{"issue":"3","key":"10187_CR18","first-page":"194","volume":"61","author":"WJ Fokkens","year":"2023","unstructured":"Fokkens WJ et al (2023) EPOS\/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023. Rhinology 61(3):194\u2013202","journal-title":"Rhinology"},{"issue":"10","key":"10187_CR19","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1111\/all.15796","volume":"78","author":"RJL van der Lans","year":"2023","unstructured":"van der Lans RJL et al (2023) Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months. Allergy 78(10):2684\u20132697","journal-title":"Allergy"},{"key":"10187_CR20","unstructured":"Bundesausschuss, G. (2024). Dossier zur Nutzenbewertung gem\u00e4\u00df \u00a7 35a SGB V. Dupilumab (Dupixent\u00ae)(webpage). Accessed, 4"},{"issue":"12","key":"10187_CR21","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s11882-023-01114-w","volume":"23","author":"CL Guo","year":"2023","unstructured":"Guo CL et al (2023) Type 2 biomarkers for the indication and response to biologics in CRSwNP. Curr Allergy Asthma Rep 23(12):703\u2013713","journal-title":"Curr Allergy Asthma Rep"},{"issue":"9","key":"10187_CR22","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1007\/s00405-024-08574-4","volume":"281","author":"SO Sarnoch","year":"2024","unstructured":"Sarnoch SO et al (2024) The value of biomarkers in the therapy of CRSwNP with biologicals-a long-term follow-up of dupilumab therapy. Eur Arch Otorhinolaryngol 281(9):4789\u20134805","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10187_CR23","doi-asserted-by":"crossref","unstructured":"Habenbacher M et al (2024) Investigation of blood count-based inflammatory biomarkers as predictors of response to dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps. Pharmaceutics, 16(11): 1370","DOI":"10.3390\/pharmaceutics16111370"},{"issue":"10209","key":"10187_CR24","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C et al (2019) Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394(10209):1638\u20131650","journal-title":"Lancet"},{"issue":"5","key":"10187_CR25","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.jaci.2010.02.020","volume":"125","author":"T Van Zele","year":"2010","unstructured":"Van Zele T et al (2010) Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol 125(5):1069\u20131076e4","journal-title":"J Allergy Clin Immunol"},{"key":"10187_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.parkreldis.2016.09.023","volume":"33","author":"M Lawton","year":"2016","unstructured":"Lawton M et al (2016) Equating scores of the University of Pennsylvania smell identification test and sniffin\u2019 sticks test in patients with parkinson\u2019s disease. Parkinsonism Relat Disord 33:96\u2013101","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"10187_CR27","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/alr.23416","volume":"14","author":"JY Lee","year":"2024","unstructured":"Lee JY et al (2024) Diagnostic criteria for eosinophilic chronic rhinosinusitis: comparative analysis and novel scoring system. Int Forum Allergy Rhinol 14(11):1746\u20131756","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10187_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.21053\/ceo.2023.00542","volume":"16","author":"SK Yang","year":"2023","unstructured":"Yang SK et al (2023) Differences in clinical and immunological characteristics according to the various criteria for tissue eosinophilia in chronic rhinosinusitis with nasal polyps. Clin Exp Otorhinolaryngol 16(4):359\u2013368","journal-title":"Clin Exp Otorhinolaryngol"},{"issue":"10","key":"10187_CR29","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1159\/000530193","volume":"184","author":"CL Guo","year":"2023","unstructured":"Guo CL et al (2023) Identification of inflammatory endotypes by clinical characteristics and nasal secretion biomarkers in chronic rhinosinusitis with nasal polyps. Int Arch Allergy Immunol 184(10):955\u2013965","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10187_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4168\/aair.2021.13.1.8","volume":"13","author":"BS Bochner","year":"2021","unstructured":"Bochner BS, Stevens WW (2021) Biology and function of eosinophils in chronic rhinosinusitis with or without nasal polyps. Allergy Asthma Immunol Res 13(1):8\u201322","journal-title":"Allergy Asthma Immunol Res"},{"issue":"8","key":"10187_CR31","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/1744666X.2023.2200164","volume":"19","author":"T Nakayama","year":"2023","unstructured":"Nakayama T, Haruna SI (2023) A review of current biomarkers in chronic rhinosinusitis with or without nasal polyps. Expert Rev Clin Immunol 19(8):883\u2013892","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10187_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.14639\/0392-100X-N2877","volume":"45","author":"E De Corso","year":"2025","unstructured":"De Corso E et al (2025) Blood and local nasal eosinophilia in chronic rhinosinusitis with nasal polyps: prevalence and correlation with severity of disease. Acta Otorhinolaryngol Ital 45(1):39\u201346","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"10","key":"10187_CR33","doi-asserted-by":"publisher","first-page":"101129","DOI":"10.1016\/j.waojou.2025.101129","volume":"18","author":"GM Pace","year":"2025","unstructured":"Pace GM et al (2025) Predictive value of tissue eosinophilia for dupilumab response in chronic rhinosinusitis with nasal polyps: a retrospective monocentric study. World Allergy Organ J 18(10):101129","journal-title":"World Allergy Organ J"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10187-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10187-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10187-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:54:10Z","timestamp":1781650450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-026-10187-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10187"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10187-y","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}